Background-Variation in outcomes after percutaneous coronary interventions (PCI) may reflect differences in quality of care. To date, however, we lack a methodology to monitor and improve national hospital 30-day mortality rates among patients undergoing PCI. Methods and Results-We developed hierarchical logistic regression models to calculate hospital risk-standardized 30-day all-cause PCI mortality rates. Due to differences in risk, patients were divided into 2 cohorts: those with ST-segment elevation myocardial infarction or cardiogenic shock, and those with no ST-segment elevation myocardial infarction and no cardiogenic shock. The models were derived using 2006 data from the CathPCI Registry linked with administrative claims data, and validated using comparable 2005 data. In the derivation cohort of the ST-segment elevation myocardial infarction or shock model (n=15 123), the unadjusted 30-day mortality rate was 9.2%. The final model included 13 variables with the observed mortality rates ranging from 1.4% to 40.3% across deciles of the predicted patient mortality rates. The 25th and 75th percentiles of the risk-standardized mortality rate were 8.5% and 9.7%, with 5th and 95th percentiles of 7.6% and 11.0%. In the derivation cohort of the no ST-segment elevation myocardial infarction and no shock model (n=110 529), the unadjusted 30-day mortality rate was 1.4%. The final model included 16 variables with the observed predicted mortality rates ranging from 0.1% to 7.0% across deciles of the predicted patient mortality rates. The 25th and 75th percentiles of the risk-standardized mortality rate across 612 hospitals were 1.3% and 1.6%, with 5th and 95th percentiles of 1.0% and 2.0%.
T he outcomes of patients undergoing percutaneous coronary intervention (PCI) depend on not only the technical skill of the interventional cardiologist, but also the coordinated efforts of the broader team of health care professionals. To bring transparency to the results achieved by hospitals, several states have developed programs to publicly report PCI mortality, and these efforts have suggested variation in hospitallevel PCI mortality that may reflect differences in quality of care. 1, 2 To date, however, there has not been a single national effort to monitor or report PCI mortality rates, in part due to the absence of mechanisms for systematically collecting and analyzing the data needed to adjust for differences in case mix across institutions that perform PCI.
Ideally, any effort to estimate hospital-specific mortality rates would use clinical information abstracted from the medical record for risk adjustment. Although this approach has been adopted by several states that report PCI mortality, 1,2 the collection of this information imposes a large burden on PCI hospitals. To create an infrastructure for monitoring PCI outcomes while minimizing the associated administrative burden, we developed models of PCI mortality using information already collected by many PCI hospitals through their participation in the American College of Cardiology (ACC) National Cardiovascular Data Registry's (NCDR) CathPCI Registry. The registry captures detailed information about patients undergoing cardiac catheterization and PCI at more than 1100 hospitals, representing more than half of the hospitals that currently perform PCI.
Previous investigators have used the CathPCI Registry to develop risk models that accurately predict patient risk, but these models are not suitable for public reporting. [3] [4] [5] As articulated in an American Heart Association Scientific Statement, risk models used to compare hospital performance must adhere to a core set of attributes including establishing a standard period of assessment and using an analytic approach that takes into account differences in case mix and volume. 6 To address this gap, the Centers for Medicare and Medicaid Services (CMS), in partnership with the NCDR, merged the clinical data from the CathPCI Registry with the administrative claims data to develop hierarchical logistic regression models that produce hospital-specific risk standardized 30-day PCI mortality rates. The mortality estimates from these models reflect the outcomes achieved by the systems of care that are involved with patients who undergo PCI. As such, this information can be used to understand and improve the overall quality of care and outcomes achieved by hospitals that perform PCI.
Methods

Data Sources
The CathPCI Registry
The CathPCI Registry is a national, voluntary cardiac catheterization laboratory registry that catalogs the clinical data and outcomes of both cardiac catheterization and PCI at >600 hospitals across the United States. Using a standardized set of data elements and definitions, the registry captures detailed information about patients undergoing PCI, including demographics, comorbid conditions, cardiac status, and coronary anatomy (www.ncdr.com). Data are collected retrospectively or concurrently and represent consecutive patients treated at each institution. Hospitals that join the CathPCI Registry agree to submit data for 100% of patients undergoing PCI procedures, including all related cardiac catheterization data. All data undergo extensive quality checks and a random sample of CathPCI sites undergo external auditing to further ensure data quality. Data are collected in a standardized format by participating hospitals and submitted electronically on a quarterly basis to NCDR. Data submitted reflects acute episodes of care, from admission to discharge.
Medicare Part A (Inpatient Data) and Enrollment Database (EDB)
Medicare Part A inpatient data contain claims paid for Medicare inpatient hospital care, skilled nursing facility care, some home health agency services, and hospice care. For this analysis, only inpatient service data from January through December for years 2005 and 2006 were used. The EDB contains Medicare beneficiary demographics, benefit coverage, and vital status.
Cohort Development
Because CathPCI dataset did not capture direct patient identifiers, data from the CathPCI Registry and Medicare Part A were linked using the following indirect patient identifiers that were available in both datasets: hospital Medicare Provider Number, patient age, sex, admission date, and discharge date. To accomplish this, we identified admissions associated with a PCI in both the CathPCI Registry (field 614 (PCI=Yes)) and CMS claims data (ICD-9-CM procedure codes: 00.66; 36.01; 36.02, 36.05-36.07). The algorithm used to derive the set of admissions in 2006 is documented in Figure 1 . When patients underwent >1 PCI during an admission, we considered only the data from the first PCI. Prior to the merge, we excluded the following patients from each dataset: age <65 years at time of admission; same-day discharges, because they would not be captured in the Part A inpatient data; admissions to hospitals with a missing or duplicate Medicare Provider Number; and admissions in which the patients had identical information regarding age, sex, admission date, discharge date, and hospital Medicare provider number (Figure 1 ). At the merge, we excluded admissions not matched by hospitals and then by age, sex, date of admission, date of discharge, and hospital Medicare provider number. We applied the following exclusions to the merged dataset: admissions in which the PCI procedure was performed after >10 days of admission as it was thought the outcomes of these patients would be less likely attributable to the care delivered at the time of or after the procedure; admissions in which the patient had been transferred from another hospital during which a PCI had been performed; admissions in whom vital status could not be determined; and admissions which would lead to duplicate attribution of deaths within 30 days of the PCI.
Patients in the merged dataset were divided into 2 cohorts: patients undergoing PCI in the setting of either acute ST-segment elevation myocardial infarction (STEMI) or cardiogenic shock (STEMI or shock cohort), and patients who had neither STEMI nor cardiogenic shock (no STEMI and no shock cohort). Of note, patients with new left bundle-branch block were grouped with STEMI patients, and patients with left bundle-branch block that was either old or of indeterminate age were grouped into the no STEMI and no shock cohort. The rationale for this division was 2-fold. First, the risk of mortality associated with PCI varies widely depending on clinical status. Patients undergoing an elective PCI are much less likely to die than patients undergoing PCI in the setting of either STEMI or cardiogenic shock. Second, certain hospitals are only permitted to perform PCI on
WHAT IS KNOWN
• The outcomes of patients undergoing percutaneous coronary intervention vary by the quality of care provided. • To date, the United States has not had a national effort to monitor or report percutaneous coronary intervention mortality rates, in part due to the absence of mechanisms for systematically collecting and analyzing the data needed to adjust for differences in case mix across institutions that perform percutaneous coronary intervention.
WHAT THE STUDY ADDS
• Two models of 30-day percutaneous coronary intervention mortality that leverage the clinical information collected by percutaneous coronary intervention hospitals through the National Cardiovascular Data Registry's CathPCI Registry. • The models produce hospital specific estimates of risk-standardized 30-day mortality rates for patients undergoing percutaneous coronary intervention. • These models are consistent with the consensus standards for publicly reported outcomes measures and have been approved by the National Quality Forum for this purpose.
patients with STEMI (ie, Primary PCI centers). This methodology is consistent with that adopted by Massachusetts' program to publicly report PCI mortality. 2
Outcome
The outcome for each cohort was 30-day all-cause mortality, measured as death due to any cause within 30 days from the date of the index PCI procedure. Vital status was determined through the Medicare EDB. 
Candidate and Final Variables
Missing Data
The percentage of missing values was <1% for all categorical variables. For these variables, the most common value was imputed. Among continuous variables, 3 had significant numbers of missing values: body mass index, glomerular filtration rate, and left ventricular ejection fraction. For body mass index, we stratified by gender and imputed the missing values to the median of the corresponding group. For glomerular filtration rate, we stratified patients into 5 categories: <30, 30-59, 60-89, ≥90, and not measured. For left ventricular ejection fraction, we stratified patients into 4 categories: ≤30%, 31-45%, >45%, and "not measured."
Analysis
The models were developed using data on PCIs performed in 2006 and validated using comparable data from 2005. In both the STEMI or shock and no STEMI and no shock cohorts, we conducted analyses of model performance using logistic regression models. To create a parsimonious model consisting of the variables most strongly associated with 30-day mortality, we selected variables using backward stepwise selection (entry P<0.05; retention P<0.01) taking into consideration the direction and magnitude of the regression coefficients. Variable selection was further confirmed repeating the selection process using bootstrap analyses with 1000 iterations. Variables were retained in the final model if they were selected in at least 80% of the iterations. To assess model performance at the patient level, we calculated the area under the receiver operating characteristic curve (AUC), explained variation as measured by the generalized R 2 statistic, and calculated the observed readmission rates in the lowest and highest deciles on the basis of the predicted readmission probabilities. To visually assess the calibration of the model (predictive ability), we grouped patients into deciles of predicted 30-day mortality and examined observed mortality across the deciles. 
Model Validation
We compared the model performance in the derivation sample with its performance in the validation cohort derived from PCI patients discharged in 2005. We calculated overfitting indices that quantify overfitting through logistic regression model in the validation sample on the basis of the risk score using the regression estimates from our derivation model. A risk score coefficient that is far from 1 and an intercept different that is far from 0 are indicative of overfitting. We also recalibrated the model in the validation set and reassessed the model performance using the metrics described above.
Risk-Standardized Mortality Rate
We combined data from the development and validation cohorts to calculate hospital-specific risk-standardized 30-day mortality rates.
To handle clustering of patient admissions within hospitals (our unit of inference), we estimated risk-standardized mortality rates (RSMRs) using hierarchical logistic regression models. 7 This approach reflects our assumption that after adjusting for patient risk and differences in procedural volume, the remaining variation is attributable to hospital quality. These rates are obtained as the ratio of the number of predicted to expected deaths, multiplied by the national rate. The predicted number of deaths in each hospital is estimated given its own patient mix and using its own hospital-specific intercept. The expected number of deaths in each hospital is estimated using its own patient mix and the average hospital-specific intercept based on all hospitals in our sample. This is a form of indirect standardization. Analyses were conducted using SAS version 9.1.3 (SAS Institute Inc, Cary, NC). We estimated the hierarchical models using the GLIMMIX procedure in SAS. The Human Investigation Committee at the Yale School of Medicine approved an exemption for the authors to use a limited data set consisting of both NCDR CathPCI data and CMS claims data for research analyses and publication.
Results
Among PCI admissions for older patients (age ≥ 65 years) in the registry, 68% were successfully matched to CMS claims data in the derivation cohort and 71% were successfully matched to CMS claims data in the validation cohort. Results of the match were similar when we varied matching criteria (eg, removing discharge date as a linking field). Within hospitals that participated in the CathPCI Registry, the characteristics of patients who matched were comparable to those of patients who did not match ( at 602 hospitals. The median hospital volume of STEMI or shock cases was 20 (interquartile range, , and the overall 30-day mortality rate was 9.2%. The development sample for the no STEMI and no shock cohort consisted of 110 529 admissions at 602 hospitals. Median hospital PCI volume in the no STEMI and no shock cohort was 133 (interquartile range, 55-244) and the national 30-day mortality rate was 1.4%.
Model Development and Validation
STEMI or Shock Model
The final risk-adjustment model for the STEMI or shock cohort included 13 variables. The variable descriptions, Wald χ 2 , and odds ratios are shown in Table 2 . The development model had excellent discrimination, calibration, and fit ( Table 3 ). The patient-level observed mortality rate ranged from 1.4% in the lowest decile of the predicted mortality to 40.3% in the highest decile of the predicted mortality, with a range of 38.9%. The area under the ROC curve was 0.83. In addition, there was an excellent correlation between the predicted and the observed mortality in the derivation cohort ( Figure 2) . We compared the model performance in the development sample with its performance in a similarly derived validation sample from 12 052 PCI patients at 458 hospitals discharged in 2005. The validation sample had a crude mortality rate of 9.0%, and model performance was not substantively different in this validation sample (ROC=0.84), as compared with the development sample. The model in the validation sample was well calibrated through the overfitting indices of (-0.03, 1.01) ( Table 3) .
No STEMI and No Shock Model
The final risk-adjustment model for the no STEMI and no shock cohort included 16 variables ( Table 4 ). The development model has excellent discrimination, calibration, and fit ( Table 5 ). The patient-level observed mortality rate in the development cohort ranges from 0.1% in the lowest decile of the predicted mortality to 7.0% in the highest decile of the predicted mortality, with a range of 6.9% (Figure 3 ). The area under the ROC curve was 0.82. We compared the model performance in the development sample with its performance in a similarly derived validation sample of 88 630 PCI patients without STEMI or Shock discharged in 2005 at 457 hospitals. The validation sample had a crude mortality rate of 1.4%. Model calibration in the validation cohort was good with overfitting indices of (-0.14, 0.95). Model performance metrics were not substantively different in the validation sample (Table 5 ). Figure 4A and 4B display the frequency distributions of the hospital-specific 30-day mortality rates, with and without risk-adjustment for the 2005 to 2006 combined STEMI or shock cohort. The observed mortality rate ranged from 0% to 100% across the 614 hospitals ( Figure 4A ). After adjusting for patient and clinical characteristics, the risk-standardized rates were found to be more normally distributed ( Figure 4B) . The 25th and 75th percentiles of the RSMRs across 614 hospitals were 8.5% and 9.7%, with 5th and 95th percentiles of 7.6% and 11.0%. The variance of the random effects was 0.1024, and the odds of all-cause 30-day mortality rates for a hospital whose random effect is 1 standard deviation above average was 1.9 times that of a hospital whose random effect is 1 standard deviation below average. Figure 5A and 5B display the frequency distributions of the hospital-specific 30-day mortality rates, with and without risk-adjustment for 2005 to 2006 combined no STEMI and no Shock cohort. The observed mortality rate ranged from 0% to 50% across the 612 hospitals ( Figure 5A ). After adjusting for patient and clinical characteristics, the risk-standardized rates were again more normally distributed ( Figure 5B ). The 25th and 75th percentiles of the RSMRs across 612 hospitals were 1.3% and 1.6%, with 5th and 95th percentiles of 1.0% and 2.0%. The variance of the random effects was 0.1325, and the odds of all-cause 30-day mortality rates for a hospital whose random effect is 1 standard deviation above average was 2.1 times that of a hospital whose random effect is 1 standard deviation below average.
30-Day Mortality Rate Distribution With and Without Risk-Adjustment
Discussion
We present 2 hierarchical logistic regression models for 30-day mortality after PCI among patients >65 years of age using data from the CathPCI Registry merged with CMS administrative data. The 2 cohorts consist of distinct PCI populations that have different outcomes allowing for valid estimates of hospital performance. The methodological approach to develop the mortality measures was designed to reflect accepted standards for publicly reported outcomes measures. 6 We derived the models using risk-adjustment variables that excluded potential complications so that the estimated risk of mortality was based on characteristics prior to, rather than during or after, the procedure. The 30-day time period provides a standardized period of assessment. To calculate RSMRs, we used a hierarchical logistic regression model, a statistical approach that takes into account the clustering of patients within hospitals and differences in sample size across hospitals.
The variables included in the risk models are consistent with those of previously published models of in-hospital PCI mortality, 3, 8 but the c statistics for our models are modestly lower. This is due in part to the longer period of assessment (30 day versus in-hospital mortality), as well the decision to stratify the cohort of patients undergoing PCI into 2 distinct populations based on the presence or absence of 2 prognostically important variables: STEMI and cardiogenic shock. As discussed, the decision to split the population is warranted due to profound differences in expected mortality and the fact that a significant number of hospitals are only approved to perform primary PCI. However, this results in greater homogeneity within each cohort and reduces model discrimination. In addition, we excluded a number of covariates including potential complications, patient race, socioeconomic status, and admission path (eg, admission from nursing home). Although these factors could improve model performance, they should not be included in risk models used to compare hospital performance. 6 The measures use a 30-day period for determining mortality after PCI. A fixed outcome period is preferable to inhospital outcomes in that variation in length of stay (LOS) does not affect performance and minimizes the opportunity for misrepresentation through mechanisms such as transferring patients. 6 In addition, the 30-day period of assessment may be a more clinically meaningful timeframe for patients, reflecting not only the outcomes of inpatient processes of care but also the transition of care to the outpatient setting. Consequently, a 30-day mortality measure may stimulate better collaboration between hospitals and their surrounding medical communities aimed at reducing mortality rates.
These activities may include ensuring patients are clinically appropriate for discharge; improving communication among providers in transitions of care; and encouraging strategies that promote disease management principles and educate patients on what symptoms to monitor, whom to contact with questions, and where and when to seek follow-up care. In this manner, information about 30-day mortality rates after PCI could be used to supplement existing quality improvement efforts.
Although the models we developed are suitable for characterizing the quality of care achieved by hospitals performing PCI, additional steps may be necessary before implementation. The models were derived from a population of elderly, fee-for-service Medicare patients undergoing PCI at programs that participated in the CathPCI Registry. Although the variables included in the models have face validity, the models will need to be tested in the broader population of patients undergoing PCI, including non-Medicare patients and the growing population of patients undergoing PCI under an outpatient or observation status. Nevertheless, the variables and explained variation of our models are similar to those of prior efforts to model in-hospital mortality after PCI, and it is unlikely that model performance would differ substantially in the broader population.
We developed the models from a dataset that linked CathPCI Registry data with Medicare FFS administrative data. As a result, 30% of eligible PCI in the NCDR were excluded from measure development. This was due in large part to the fact that 19% of patients ≥65 years of age are enrolled in Medicare Advantage and are absent from the FFS claims data (Medicare Fact Sheet). Other contributing factors include patients ineligible for Medicare (eg non-US citizens), patients who were not admitted to the hospital (observation stay PCI), patients with nongovernmental insurance, and inaccuracies in linking fields. The fact that the characteristics and in-hospital outcomes of patients who did and did not match were similar supports the generalizability of the risk models. Nevertheless, the use of direct patient identifiers such as social security number to link to external databases such as the Social Security Death Index or National Death Index would be necessary to ensure the accurate determination of the vital status of all PCIs, not simply those performed on Medicare FFS patients.
More than a third of hospitals that perform PCI in the United States do not currently participate in the CathPCI Registry. Accordingly, public reporting would require the development of mechanisms to collect and merge data from all hospitals either through CathPCI or other mechanisms. In addition, any effort to publicly report hospital PCI outcomes requires that the data submitted by hospitals be complete, consistent, and accurate. As such, public reporting would need to be accompanied by efforts to ensure data completeness and quality such as surveillance for systematic variation in case mix (eg unexpectedly high proportion of salvage PCI or cardiogenic shock), confirmation of the accuracy of submitted data through targeted chart abstraction, and, potentially, systematic adjudication of cases that are vulnerable to misclassification. 9 Certain aspects of our analysis warrant further consideration. First, there may be unmeasured factors that could impact hospitals' RSMRs. Examples of this include hemoglobin, functional status, and prehospital delays for STEMI patients, none of which are routinely collected in version 3 of the CathPCI Registry. All of these factors have been found to be significantly associated with patient outcomes after PCI, but the impact on hospital-level estimates of PCI outcomes is not known. Additional work will be necessary to identify ways to improve the risk models if and when such variables become available. In addition, we will need to update the risk models to incorporate alternative methods of handling missing data such as multiple imputation, and retaining continuous variables such as body mass index and LVEF as continuous variables rather than categorizing them. We plan on pursuing these activities when the measures undergo re-endorsement evaluation by the NQF. Finally, the risk models do not include hospital characteristics such as procedural volume that are associated with differences in mortality after PCI. These factors may account for variation in the quality of care as reflected by hospitals' RSMR, and adjusting for them could obscure important differences between hospitals.
In summary, we present 2 registry-based models that produce estimates of hospital risk-standardized 30-day mortality rates for patients undergoing PCI and can be used to evaluate quality of care. These models are consistent with the consensus standards for publicly reported outcomes measures and have been approved by the National Quality Forum.
